Lymphoedema of the lower extremities - background, pathophysiology and diagnostic considerations

Clinical Physiology and Functional Imaging

Volumn 30, Issue 6, 2010, Pages 389-398

  Jensen, Mads R ^a   Simonsen, Lene ^a   Karlsmark, Tonny ^a   Bülow, Jens ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Aetiology; Chronic oedema; Interstitial fluid regulation; Lymphoscintigraphy; Physiology of the lymphatic system; Removal rate constant

Indexed keywords

ANATOMY; DIAGNOSTIC TEST; HOMEOSTASIS; HUMAN; INTERSTITIAL FLUID; LOWER LEG; LYMPHATIC SYSTEM; LYMPHEDEMA; LYMPHOSCINTIGRAPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

HOMEOSTASIS; HUMANS; HYDROSTATIC PRESSURE; LOWER EXTREMITY; LYMPHATIC SYSTEM; LYMPHEDEMA; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RISK FACTORS;

EID: 78649456703     PISSN: 14750961     EISSN: 1475097X     Source Type: Journal    
DOI: 10.1111/j.1475-097X.2010.00969.x     Document Type: Review

References (95)

1. Aboul-Enein A, Eshmawy I, Arafa S, Abboud A. The role of lymphovenous communication in the development of postmastectomy lymphedema. Surgery (1984); 95: 562-566.
2. Aukland K, Reed RK. Interstitial-lymphatic mechanisms in the control of extracellular fluid volume. Physiol Rev (1993); 73: 1-78.
3. Barrett T, Choyke PL, Kobayashi H. Imaging of the lymphatic system: new horizons. Contrast Media Mol Imaging (2006); 1: 230-245.
4. Bates DO, Levick JR, Mortimer PS. Change in macromolecular composition of interstitial fluid from swollen arms after breast cancer treatment, and its implications. Clin Sci (Lond) (1993); 85: 737-746.
5. Bennett Britton TM, Wallace SM, Wilkinson IB, Mortimer PS, Peters AM, Purushotham AD. Sympathetic nerve damage as a potential cause of lymphoedema after axillary dissection for breast cancer. Br J Surg (2009); 96: 865-869.
6. Bergqvist L, Strand SE, Persson BR. Particle sizing and biokinetics of interstitial lymphoscintigraphic agents. Semin Nucl Med (1983); 13: 9-19.
7. Board J, Harlow W. Lymphoedema 1: components and function of the lymphatic system. Br J Nurs (2002); 11: 304-309.
8. Bourgeois P. Scintigraphic investigations of the lymphatic system: the influence of injected volume and quantity of labeled colloidal tracer. J Nucl Med (2007); 48: 693-695.
9. Bourgeois P, Leduc O, Belgrado JP, Leduc A. Scintigraphic investigations of the superficial lymphatic system: quantitative differences between intradermal and subcutaneous injections. Nucl Med Commun (2009); 30: 270-274.
10. Brautigam P, Vanscheidt W, Foldi E, Krause T, Moser E. The importance of the subfascial lymphatics in the diagnosis of lower limb edema: investigations with semiquantitative lymphoscintigraphy. Angiology (1993); 44: 464-470.
11. Brautigam P, Foldi E, Schaiper I, Krause T, Vanscheidt W, Moser E. Analysis of lymphatic drainage in various forms of leg edema using two compartment lymphoscintigraphy. Lymphology (1998); 31: 43-55.
12. Brice G, Child AH, Evans A, Bell R, Mansour S, Burnand K, Sarfarazi M, Jeffery S, Mortimer P. Milroy disease and the VEGFR-3 mutation phenotype. J Med Genet (2005); 42: 98-102.
13. Bridenbaugh EA, Gashev AA, Zawieja DC. Lymphatic muscle: a review of contractile function. Lymphat Res Biol (2003); 1: 147-158.
14. Brorson H, Svensson H, Norrgren K, Thorsson O. Liposuction reduces arm lymphedema without significantly altering the already impaired lymph transport. Lymphology (1998); 31: 156-172.
15. Brorson H, Ohlin K, Olsson G, Nilsson M. Adipose tissue dominates chronic arm lymphedema following breast cancer: an analysis using volume rendered CT images. Lymphat Res Biol (2006); 4: 199-210.
16. Brorson H, Ohlin K, Olsson G, Karlsson MK. Breast cancer-related chronic arm lymphedema is associated with excess adipose and muscle tissue. Lymphat Res Biol (2009); 7: 3-10.
17. Burnand KG, McGuinness CL, Lagattolla NR, Browse NL, El-Aradi A, Nunan T. Value of isotope lymphography in the diagnosis of lymphoedema of the leg. Br J Surg (2002); 89: 74-78.
18. Cambria RA, Gloviczki P, Naessens JM, Wahner HW. Noninvasive evaluation of the lymphatic system with lymphoscintigraphy: a prospective, semiquantitative analysis in 386 extremities. J Vasc Surg (1993); 18: 773-782.
19. Carena M, Campini R, Zelaschi G, Rossi G, Aprile C, Paroni G. Quantitative lymphoscintigraphy. Eur J Nucl Med (1988); 14: 88-92.
20. Damstra RJ, Mortimer PS. Diagnosis and therapy in children with lymphoedema. Phlebology (2008); 23: 276-286.
21. Damstra RJ, Van Steensel MA, Boomsma JH, Nelemans P, Veraart JC. Erysipelas as a sign of subclinical primary lymphoedema: a prospective quantitative scintigraphic study of 40 patients with unilateral erysipelas of the leg. Br J Dermatol (2008); 158: 1210-1215.
22. Dutch Society of Nuclear Medicine. Recommendations in Nuclear Medicine. Utrecht. 88-97. 2007.
23. Engeset A, Olszewski W, Jaeger PM, Sokolowski J, Theodorsen L. Twenty-four hour variation in flow and composition of leg lymph in normal men. Acta Physiol Scand (1977); 99: 140-148.
24. Földi M, Földi E. Földi's Textbook of Lymphology - for Physicians and Lymphedema Therapists (2006), 2nd edn. Elsevier Urban & Fischer, München, Germany.
25. Gashev AA. Physiologic aspects of lymphatic contractile function: current perspectives. Ann N Y Acad Sci (2002); 979: 178-187.
26. Global Alliance to Eliminate Lymphatic Filariasis. 10 Years of Progress Towards Elimination: Success in a Changing Policy Environment. 2008.
27. Gloviczki P, Calcagno D, Schirger A, Pairolero PC, Cherry KJ, Hallett JW, Wahner HW. Noninvasive evaluation of the swollen extremity: experiences with 190 lymphoscintigraphic examinations. J Vasc Surg (1989); 9: 683-689.
28. Golueke PJ, Montgomery RA, Petronis JD, Minken SL, Perler BA, Williams GM. Lymphoscintigraphy to confirm the clinical diagnosis of lymphedema. J Vasc Surg (1989); 10: 306-312.
29. Gothard L, Stanton A, MacLaren J, Lawrence D, Hall E, Mortimer P, Parkin E, Pritchard J, Risdall J, Sawyer R, Woods M, Yarnold J. Non-randomised phase II trial of hyperbaric oxygen therapy in patients with chronic arm lymphoedema and tissue fibrosis after radiotherapy for early breast cancer. Radiother Oncol (2004); 70: 217-224.
30. Halberg N, Khan T, Trujillo ME, Wernstedt-Asterholm I, Attie AD, Sherwani S, Wang ZV, Landskroner-Eiger S, Dineen S, Magalang UJ, Brekken RA, Scherer PE. Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol (2009); 29: 4467-4483.
31. Havas E, Parviainen T, Vuorela J, Toivanen J, Nikula T, Vihko V. Lymph flow dynamics in exercising human skeletal muscle as detected by scintography. J Physiol (1997); 504(Pt 1): 233-239.
32. Ikomi F, Hanna GK, Schmid-Schonbein GW. Size- and surface-dependent uptake of colloid particles into the lymphatic system. Lymphology (1999); 32: 90-102.
33. Jager G, Doller W, Roth R. Quality-of-life and body image impairments in patients with lymphedema. Lymphology (2006); 39: 193-200.
34. Kerchner K, Fleischer A, Yosipovitch G. Lower extremity lymphedema update: pathophysiology, diagnosis, and treatment guidelines. J Am Acad Dermatol (2008); 59: 324-331.
35. Kleinhans E, Baumeister RG, Hahn D, Siuda S, Bull U, Moser E. Evaluation of transport kinetics in lymphoscintigraphy: follow-up study in patients with transplanted lymphatic vessels. Eur J Nucl Med (1985); 10: 349-352.
36. Lane K, Worsley D, McKenzie D. Lymphoscintigraphy to evaluate the effects of upper body dynamic exercise and handgrip exercise on radiopharmaceutical clearance from hands of healthy females. Lymphat Res Biol (2005); 3: 16-24.
37. Lane K, Dolan L, Worsley D, McKenzie D. Lymphoscintigraphy to evaluate the effect of high versus low intensity upper body dynamic exercise on lymphatic function in healthy females. Lymphat Res Biol (2006); 4: 159-165.
38. Levick JR. Revision of the Starling principle: new views of tissue fluid balance. J Physiol (2004); 557: 704.
39. Levick JR, Michel CC. Microvascular fluid exchange and the revised Starling principle. Cardiovasc Res (2010); 87: 198-210.
40. Lymphoedema framework. Best Practice for the Management of Lymphoedema. International consensus (2006). MEP Ltd, London.
41. Lynch PM, Delano FA, Schmid-Schonbein GW. The primary valves in the initial lymphatics during inflammation. Lymphat Res Biol (2007); 5: 3-10.
42. Mariman EC, Wang P. Adipocyte extracellular matrix composition, dynamics and role in obesity. Cell Mol Life Sci (2010); 67: 1277-1292.
43. Miranda F Jr, Perez MC, Castiglioni ML, Juliano Y, Amorim JE, Nakano LC, De BN Jr, Lustre WG, Burihan E. Effect of sequential intermittent pneumatic compression on both leg lymphedema volume and on lymph transport as semi-quantitatively evaluated by lymphoscintigraphy. Lymphology (2001); 34: 135-141.
44. Modi S, Stanton AW, Mellor RH, Peters AM, Levick JR, Mortimer PS. Regional distribution of epifascial swelling and epifascial lymph drainage rate constants in breast cancer-related lymphedema. Lymphat Res Biol (2005); 3: 3-15.
45. Modi S, Stanton AW, Mortimer PS, Levick JR. Clinical assessment of human lymph flow using removal rate constants of interstitial macromolecules: a critical review of lymphoscintigraphy. Lymphat Res Biol (2007a); 5: 183-202.
46. Modi S, Stanton AW, Svensson WE, Peters AM, Mortimer PS, Levick JR. Human lymphatic pumping measured in healthy and lymphoedematous arms by lymphatic congestion lymphoscintigraphy. J Physiol (2007b); 583: 271-285.
47. Mortimer PS. The pathophysiology of lymphedema. Cancer (1998); 83: 2798-2802.
48. Mortimer PS, Levick JR. Chronic peripheral oedema: the critical role of the lymphatic system. Clin Med (2004); 4: 448-453.
49. Mostbeck A, Partsch H. Isotope lymphography--possibilities and limits in evaluation of lymph transport. Wien Med Wochenschr (1999); 149: 87-91.
50. Murfee WL, Rappleye JW, Ceballos M, Schmid-Schonbein GW. Discontinuous expression of endothelial cell adhesion molecules along initial lymphatic vessels in mesentery: the primary valve structure. Lymphat Res Biol (2007); 5: 81-89.
51. Noer I, Lassen NA. Evidence of active transport (filtration?) of plasma proteins across the capillary walls in muscle and subcutis. Acta Physiol Scand Suppl (1979); 463: 105-110.
52. Olszewski WL. The lymphatic system in body homeostasis: physiological conditions. Lymphat Res Biol (2003); 1: 11-21.
53. Olszewski WL, Engeset A. Intrinsic contractility of prenodal lymph vessels and lymph flow in human leg. Am J Physiol (1980); 239: H775-H783.
54. Olszewski W, Engeset A, Jaeger PM, Sokolowski J, Theodorsen L. Flow and composition of leg lymph in normal men during venous stasis, muscular activity and local hyperthermia. Acta Physiol Scand (1977); 99: 149-155.
55. O'Mahony S, Rose SL, Chilvers AJ, Ballinger JR, Solanki CK, Barber RW, Mortimer PS, Purushotham AD, Peters AM. Finding an optimal method for imaging lymphatic vessels of the upper limb. Eur J Nucl Med Mol Imaging (2004); 31: 555-563.
56. Pain SJ, Nicholas RS, Barber RW, Ballinger JR, Purushotham AD, Mortimer PS, Peters AM. Quantification of lymphatic function for investigation of lymphedema: depot clearance and rate of appearance of soluble macromolecules in blood. J Nucl Med (2002); 43: 318-324.
57. Pain SJ, Barber RW, Ballinger JR, Solanki CK, O'Mahony S, Mortimer PS, Purushotham A, Peters AM. Side-to-side symmetry of radioprotein transfer from tissue space to systemic vasculature following subcutaneous injection in normal subjects and patients with breast cancer. Eur J Nucl Med Mol Imaging (2003); 30: 657-661.
58. Pain SJ, Barber RW, Ballinger JR, Solanki CK, Mortimer PS, Purushotham AD, Peters AM. Local vascular access of radioprotein injected subcutaneously in healthy subjects and patients with breast cancer-related lymphedema. J Nucl Med (2004a); 45: 789-796.
59. Pain SJ, Barber RW, Ballinger JR, Solanki CK, Mortimer PS, Purushotham AD, Peters AM. Tissue-to-blood transport of radiolabelled immunoglobulin injected into the web spaces of the hands of normal subjects and patients with breast cancer-related lymphoedema. J Vasc Res (2004b); 41: 183-192.
60. Pain SJ, Purushotham AD, Barber RW, Ballinger JR, Solanki CK, Mortimer PS, Peters AM. Variation in lymphatic function may predispose to development of breast cancer-related lymphoedema. Eur J Surg Oncol (2004c); 30: 508-514.
61. Pain SJ, Barber RW, Solanki CK, Ballinger JR, Britton TB, Mortimer PS, Purushotham AD, Peters AM. Short-term effects of axillary lymph node clearance surgery on lymphatic physiology of the arm in breast cancer. J Appl Physiol (2005); 99: 2345-2351.
62. Partsch H. Assessment of abnormal lymph drainage for the diagnosis of lymphedema by isotopic lymphangiography and by indirect lymphography. Clin Dermatol (1995); 13: 445-450.
63. Partsch H. Practical aspects of indirect lymphography and lymphoscintigraphy. Lymphat Res Biol (2003); 1: 71-73.
64. Piller N, Carati C. The diagnosis and treatment of peripheral lymphedema. Lymphology (2009); 42: 146-147.
65. Radhakrishnan K, Rockson SG. The clinical spectrum of lymphatic disease. Ann N Y Acad Sci (2008); 1131: 155-184.
66. Reddy ST, Berk DA, Jain RK, Swartz MA. A sensitive in vivo model for quantifying interstitial convective transport of injected macromolecules and nanoparticles. J Appl Physiol (2006); 101: 1162-1169.
67. Rezaie T, Ghoroghchian R, Bell R, Brice G, Hasan A, Burnand K, Vernon S, Mansour S, Mortimer P, Jeffery S, Child A, Sarfarazi M. Primary non-syndromic lymphoedema (Meige disease) is not caused by mutations in FOXC2. Eur J Hum Genet (2008); 16: 300-304.
68. Rijke AM, Croft BY, Johnson RA, De Jongste AB, Camps JA. Lymphoscintigraphy and lymphedema of the lower extremities. J Nucl Med (1990); 31: 990-998.
69. Rockson SG. Diagnosis and management of lymphatic vascular disease. J Am Coll Cardiol (2008); 52: 799-806.
70. Rockson SG. The unique biology of lymphatic edema. Lymphat Res Biol (2009); 7: 97-100.
71. Rockson SG, Rivera KK. Estimating the population burden of lymphedema. Ann N Y Acad Sci (2008); 1131: 147-154.
72. Rutkowski JM, Swartz MA. A driving force for change: interstitial flow as a morphoregulator. Trends Cell Biol (2007); 17: 44-50.
73. Scarsbrook AF, Ganeshan A, Bradley KM. Pearls and pitfalls of radionuclide imaging of the lymphatic system. Part 2: evaluation of extremity lymphoedema. Br J Radiol (2007); 80: 219-226.
74. Schacht V, Luedemann W, Abels C, Berens von RD. Anatomy of the subcutaneous lymph vascular network of the human leg in relation to the great saphenous vein. Anat Rec (Hoboken) (2009); 292: 87-93.
75. Schmid-Schonbein GW. The second valve system in lymphatics. Lymphat Res Biol (2003); 1: 25-29.
76. Soo JK, Bicanic TA, Heenan S, Mortimer PS. Lymphatic abnormalities demonstrated by lymphoscintigraphy after lower limb cellulitis. Br J Dermatol (2008); 158: 1350-1353.
77. Stanton AW, Svensson WE, Mellor RH, Peters AM, Levick JR, Mortimer PS. Differences in lymph drainage between swollen and non-swollen regions in arms with breast-cancer-related lymphoedema. Clin Sci (Lond) (2001); 101: 131-140.
78. Stanton AW, Modi S, Mellor RH, Peters AM, Svensson WE, Levick JR, Mortimer PS. A quantitative lymphoscintigraphic evaluation of lymphatic function in the swollen hands of women with lymphoedema following breast cancer treatment. Clin Sci (Lond) (2006); 110: 553-561.
79. Stanton AW, Modi S, Nett Britton TM, Purushotham AD, Peters AM, Levick JR, Mortimer PS. Lymphatic drainage in the muscle and subcutis of the arm after breast cancer treatment. Breast Cancer Res Treat (2009); 117: 549-557.
80. Strand SE, Persson BR. Quantitative lymphoscintigraphy I: basic concepts for optimal uptake of radiocolloids in the parasternal lymph nodes of rabbits. J Nucl Med (1979); 20: 1038-1046.
81. Suga K, Kume N, Matsunaga N, Motoyama K, Hara A, Ogasawara N. Assessment of leg oedema by dynamic lymphoscintigraphy with intradermal injection of technetium-99m human serum albumin and load produced by standing. Eur J Nucl Med (2001); 28: 294-303.
82. Svensson W, Glass DM, Bradley D, Peters AM. Measurement of lymphatic function with technetium-99m-labelled polyclonal immunoglobulin. Eur J Nucl Med (1999); 26: 504-510.
83. Swartz MA. The physiology of the lymphatic system. Adv Drug Deliv Rev (2001); 50: 3-20.
84. Swartz MA, Fleury ME. Interstitial flow and its effects in soft tissues. Annu Rev Biomed Eng (2007); 9: 229-256.
85. Szuba A, Shin WS, Strauss HW, Rockson S. The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema. J Nucl Med (2003); 44: 43-57.
86. Tiwari A, Cheng KS, Button M, Myint F, Hamilton G. Differential diagnosis, investigation, and current treatment of lower limb lymphedema. Arch Surg (2003); 138: 152-161.
87. Trayhurn P, Wang B, Wood IS. Hypoxia and the endocrine and signalling role of white adipose tissue. Arch Physiol Biochem (2008); 114: 267-276.
88. Vaqas B, Ryan TJ. Lymphoedema: pathophysiology and management in resource-poor settings - relevance for lymphatic filariasis control programmes. Filaria J (2003); 2: 4.
89. Wahl RL, Liebert M, Wilson BS, Petry NA. Radiolabeled antibodies, albumin and antimony sulfide colloid: a comparison as lymphoscintigraphic agents. Int J Rad Appl Instrum B (1988); 15: 243-250.
90. Warren AG, Brorson H, Borud LJ, Slavin SA. Lymphedema: a comprehensive review. Ann Plast Surg (2007); 59: 464-472.
91. Weiss M, Gildehaus FJ, Brinkbaumer K, Makowski M, Hahn K. Lymph kinetics with technetium-99m labeled radiopharmaceuticals. Animal studies. Nuklearmedizin (2005); 44: 156-165.
92. Weissleder H, Weissleder R. Lymphedema: evaluation of qualitative and quantitative lymphoscintigraphy in 238 patients. Radiology (1988); 167: 729-735.
93. Williams WH, Witte CL, Witte MH, McNeill GC. Radionuclide lymphangioscintigraphy in the evaluation of peripheral lymphedema. Clin Nucl Med (2000); 25: 451-464.
94. Zawieja DC. Contractile physiology of lymphatics. Lymphat Res Biol (2009); 7: 87-96.
95. Zoltzer H. Initial lymphatics-morphology and function of the endothelial cells. Lymphology (2003); 36: 7-25.